Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cimpress plc - Ordinary Shares (NQ:CMPR)

95.51 -2.18 (-2.23%)
Streaming Delayed Price Updated: 11:46 AM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cimpress plc - Ordinary Shares

< Previous 1 2 3 Next >
News headline image
Cimpress Touts AI Tailwind, Elevated Products as It Reaffirms 2026 Growth Outlook ↗
Cimpress (NASDAQ:CMPR) told investors at Needham Research’s 21st TMT Consumer Conference that it expects continued growth from its web-to-print mass customization model, newer product categories and... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Cimpress (CMPR) Q3 2026 Earnings Transcript ↗
Cimpress (CMPR) Q3 2026 Earnings Transcript 
Via The Motley Fool
Cimpress plc (NASDAQ:CMPR) Delivers Massive Q3 Earnings Beat with 208% EPS Surprise ↗
Via Chartmill
Topics Earnings
News headline image
Cimpress (CMPR) Q2 2025 Earnings Call Transcript ↗
Cimpress (CMPR) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
CIMPRESS PLC (NASDAQ:CMPR) Q2 2026 Earnings Top Estimates with Strong Revenue and EPS Beat ↗
Via Chartmill
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
According to SEC Filing, Thomas W. Smith Trimmed Yelp Stake as Local Services Advertising Reshapes the Business ↗
A recent SEC filing shows that investment manager Thomas W. Smith reduced his position in Yelp during the fourth quarter. Yelp’s platform helps people find local services and connects them with... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cimpress (CMPR) Q2 2026 Earnings Call Transcript ↗
Cimpress (CMPR) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
CIMPRESS PLC (NASDAQ:CMPR) Beats Q1 FY2026 Revenue and EPS Estimates ↗
Cimpress (CMPR) Q1 FY2026 earnings beat analyst estimates for both revenue and EPS, though the market reaction was muted. 
Via Chartmill
Topics Earnings
News headline image
Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 30, 2025 ↗
 
Via Benzinga
News headline image
What to Expect from Cimpress's Earnings ↗
 
Via Benzinga
News headline image
Cimpress (CMPR) Q4 Revenue Rises 4% ↗
Via The Motley Fool
Topics Emissions World Trade
News headline image
CIMPRESS PLC (NASDAQ:CMPR) Reports Mixed Q4 and Fiscal 2025 Results with Revenue Beat but EPS Miss ↗
Cimpress (CMPR) reported Q4 2025 results with revenue beating estimates but a surprise EPS loss. Shares remained flat post-announcement amid mixed performance. Earnings call set for July 30. 
Via Chartmill
Topics Earnings
News headline image
3 Industrials Stocks Standing Out for Growth and Analyst Optimism
Industrials stocks have thrived so far in 2025, with these three names in particular standing out among Wall Street analysts. 
Via MarketBeat
Topics Earnings Government World Trade
News headline image
Earnings Breakdown: Cimpress Q2 ↗
 
Via Benzinga
News headline image
Cimpress: Q2 Earnings Insights ↗
 
Via Benzinga
News headline image
Cimpress Q2 Earnings Assessment ↗
 
Via Benzinga
News headline image
Earnings Summary: Cimpress Q2 ↗
 
Via Benzinga
News headline image
Why Cimpress Stock Skyrocketed Today ↗
The mass-customization company delivered a strong quarter and raised its full-year profitability guidance. 
Via The Motley Fool
News headline image
Earnings Scheduled For January 29, 2025 ↗
 
Via Benzinga
News headline image
Why Cimpress Stock Broke Down on Thursday ↗
Is Cimpress a bargain buy now? The print-to-ship specialist's stock took a deep dive after the company reported mixed results in Q1 2025. 
Via The Motley Fool
News headline image
CMPR Stock Earnings: Cimpress Beats EPS, Beats Revenue for Q4 2024 ↗
CMPR stock results show that Cimpress beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
CMPR Stock Earnings: Cimpress Misses EPS, Misses Revenue for Q3 2024 ↗
CMPR stock results show that Cimpress missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024. 
Via InvestorPlace
News headline image
Bull Of The Day: H&R Block ↗
H&R Block’s fiscal third quarter is most crucial for the company as it leads up to the tax filing deadline which is typically April 15. 
Via Talk Markets
News headline image
Is It Too Late to Buy Fiverr International Stock? ↗
Fiverr's stock has soared more than 30% higher in recent weeks. Is there any room for further price gains? The answer might surprise you. 
Via The Motley Fool
News headline image
Dow Jumps 250 Points; Honeywell Issues Weak Forecast ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The... 
Via Benzinga
Topics Stocks
News headline image
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
Why Cimpress Stock Is Up After Earnings ↗
Cimpress beat estimated earnings by 72.58%, reporting quarterly earnings of $2.14 per shares versus the analyst consensus estimate of $1.24. The company reported quarterly sales of $921.36 million... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.